Article
Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants.
The Journal of biological chemistry - 27 Sept 2002
Opi Sandrine, Péloponèse Jean-Marie, Esquieu Didier, Campbell Grant, de Mareuil Jean, Walburger Anne, Solomiac Murielle, Grégoire Catherine, Bouveret Emmanuelle, Yirrell David L, Loret Erwann P
Abstract excerpt
Clinical studies show that in the absence of anti-retroviral therapy an immune response against the human immunodeficiency virus type 1 (HIV-1), transacting transcriptional activator (Tat) protein correlates with long term non-progression. The purpose of this study is to try to understand what can trigger an effective immune response against Tat. We used five Tat variants from HIV strains identified in different...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
